Structure (51662 1660 Structure)
Dexamethasone Sodium Phosphate Injection
Product Images NDC 51662-1660
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dexamethasone Sodium Phosphate (NDC 51662-1660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Vial Label (51662 1660 1 Vial Label)
This text provides information about a medication called Dexamethasone. It is a solution with a concentration of 20 mg per 5 mL (4 mg/mL) and indicates that it can be used for intravenous, intramuscular, or intra-articular administration.*
Rfid Label (51662 1660 1 Vial Rfid)
This text provides information about a product with the manufacturer's insert information for distribution by HF Acquisitions Co., LLC based in Mukilteo, WA 98275. The text also indicates that the product is for prescription use only.*
Pouch Label (51662 1660 2 Pouch Label)
This is a description of Dexamethasone Sodium Phosphate injection, USP 20mg/5mL (4mg/mL) in a 5mL vial. The medication is intended for intravenous, intramuscular, intralesional, and intra-articular soft tissue use. The product is a steroid solution equivalent to 4mg Dexamethasone Phosphate, containing Sodium Citrate Anhydrous, Benzyl Alcohol, and Water for Injection. The package insert provides instructions for proper usage, storage conditions (20 to 25 degrees Celsius), and caution to avoid freezing and exposure to light. The medicine is manufactured by HF Acquisition Co., LLC in Mukilteo, WA, 98275.*
Rfid Label (51662 1660 3 Case)
This is information about Dexamethasone Sodium Phosphate Injection, USP containing 20mg/5mL (4mg/mL) in a 5mL vial. The medication is to be used for intravenous, intramuscular, intralesional, intra-articular, or soft tissue use. Each mL contains dexamethasone sodium phosphate equivalent to dexamethasone phosphate, along with other components. The product should be stored between 2 to 25 degrees Celsius, protected from light and freezing, and not autoclaved. For more details on usage and storage, refer to the package insert provided by the manufacturer, HFA Acquisition Co., LLC.*
Case Label (51662 1660 3 Case Label)
This text provides information about a product identification number: (01)40351662166039 and a manufacture identification number: (10)789210. It also mentions a note to see the manufacturer's insert. The product seems to be distributed by HF Acquisitions Co., LLC based in Mukilteo, WA 98275.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
